CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 55(Granted Patents)

Location History:

E. Syracuse, NY (US) (1995 - 1999)
East Syracuse, NY (US) (1995 - 2006)
Monmouth Junction, NJ (US) (2007 - 2019)

Company Filing History:

12 out of 3,681

Bristol-myers Squibb Compnay

patents

1 out of 1

Women First Healthcare, Inc.

Years Active: 1995-2019

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10494400 - Hepatitis C virus inhibitors (2019-12-03),

2. 7968555 - Intermediates in the preparation of entecavir via carbon-silicon oxidation (2011-06-28),

3. 7786300 - Process for preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation (2010-08-31),

4. 7511139 - Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation (2009-03-31),

5. 7205402 - Synthesis of a benzoxazinone (2007-04-17),

6. 7034152 - Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one (2006-04-25),

7. 7012158 - Processes for the production of α-difluoromethyl ornithine (DFMO) (2006-03-14),

8. 6730809 - Processes for the production of &agr;-difluoromethyl ornithine (DFMO) (2004-05-04),

9. 6242614 - Semi-synthesis of paclitaxel using dialkyldichlorosilanes (2001-06-05),

10. 6215000 - Crystalline complexes of baccatin III with imidazole, 2-methylimidazole or isopropanol (2001-04-10),

11. 6008347 - N-substituted 2-azetidinones (1999-12-28),

12. 5688926 - Process of preparing etoposide phosphate and etoposide (1997-11-18),

13. 5459248 - Process of preparing etoposide phosphate and etoposide (1995-10-17),

14. 5412092 - N-substituted 2-azetidinones (1995-05-02),

Title: The Innovative Contributions of Purushotham Vemishetti

Introduction

Purushotham Vemishetti is a notable inventor based in Monmouth Junction, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, he has made remarkable strides in developing treatments for various medical conditions, particularly in the realm of viral infections.

Latest Patents

Among his latest patents, Vemishetti has focused on Hepatitis C virus inhibitors. His work includes methods for making asunaprevir, which is a useful treatment for Hepatitis C virus (HCV) infection, along with its intermediates. Additionally, he has developed processes for preparing entecavir and novel intermediates thereof using carbon-silicon oxidation, showcasing his innovative approach to pharmaceutical chemistry.

Career Highlights

Throughout his career, Vemishetti has worked with prominent companies such as Bristol-Myers Squibb Company and Women First Healthcare, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Maotang X Zhou and Emily A Reiff, with whom he has collaborated on various projects, further enhancing the impact of his inventions.

Conclusion

Purushotham Vemishetti's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations reflect a commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.